Central effect of botulinum toxin type A in humans

International Journal of Neuroscience

Volumn 116, Issue 6, 2006, Pages 667-680

  Kim, Dae Yul ^a   Oh, Byung Mo ^b   Paik, Nam Jong ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Botulinum toxin type A; Central effect; Intracortical inhibition; Transcranial magnetic stimulation

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BRAIN CORTEX; COLD SENSATION; CONTROLLED STUDY; DRUG EFFECT; EVOKED MUSCLE RESPONSE; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; INJECTION SITE PAIN; MALE; MOTOR CORTEX; MUSCLE CONTRACTION; NORMAL HUMAN; STATISTICAL SIGNIFICANCE; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; BOTULINUM TOXIN TYPE A; CEREBRAL CORTEX; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; NEUROTOXINS; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33745058028     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450600674525     Document Type: Article

References (32)

1. Abbruzzese, G., Buccolieri, A., Marchese, R., Trompetto, C., Mandich, P., & Schieppati, M. (1997). Intracortical inhibition and facilitation are abnormal in Huntington's disease: A paired magnetic stimulation study. Neuroscience Letters, 228, 87-90.
2. Bertasi, V., Bertolasi, L., Frasson, E., & Priori, A. (2000). The excitability of human cortical inhibitory circuits responsible for the muscle silent period after transcranial brain stimulation. Experimental Brain Research, 132, 384-389.
3. Black, J. D., & Dolly, J. O. (1987). Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous system. Neuroscience, 23, 767-769.
4. Boroff, D. A., & Chen, G. S. (1997). On the question of permeability of the blood-brain barrier to BTA. Brain, 120, 409-416.
5. Boroojerdi, B., Cohen, L. G., & Hallett, M. (2003). Effects of botulinum toxin on motor system excitability in patients with writer's cramp. Neurology, 61, 1546-1550.
6. Brashear, A., Lew, M. F., Dykstra, D. D., Comella, C. L., Factor, S. A., Rodnitzky, R. L., Trosch, R., Singer, C., Brin, M. F., Murray, J. J., Wallace, J. D., Willmer-Hulme, A., & Koller, M. (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology, 53, 1439-1446.
7. Brin, M. F. (1997). Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle & Nerve. Supplement, 6, S146-S168.
8. Cantello, R., Gianelli, M., Civardi, C., & Mutani, R. (1992). Magnetic brain stimulation: The silent period after the motor evoked potential. Neurology, 42, 1951-1959.
9. Cheshire, W. P., Abashian, S. W., & Mann, J. D. (1994). Botulinum toxin in the treatment of myofascial pain syndrome. Pain, 59, 65-69.
10. Curra, A., Trompetto, C., Abbruzzese, G., & Berardelli, A. (2004). Central effects of borulinum toxin type A: Evidence and supposition. Movement Disorders, 19, S60-S64.
11. DasGupta, B. R., & Tepp, W. (1993). Protease activity of botulinum neurotoxin type E and its light chain: Cleavage of actin. Biochimical and Biophysical Research Communications, 190, 470-474.
12. Davey, N. J., Romaiguere, P., Maskill, D. W., & Ellaway, P. H. (1994). Suppression of voluntary motor activity revealed using transcranial magnetic stimulation on the motor cortex. Journal of Physiology, 477, 223-235.
13. Fehlings, D., Rang, M., Glazier, J., & Steele, C. (2000). An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. The Journal of Pediatrics, 137, 331-337.
14. Freund, B. J., & Schwartz, M. (2000). Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study. Headache, 40, 231-236.
15. Garner, C. G., Straube, A., Witt, T. N., & Oertel, W. H. (1993). Time course of distant effects of local injections of botulinum toxin. Movement Disorders, 8, 33-37.
16. Gilio, F., Curra, A., Lorenzano, C., Modugno, N., Manfredi, M., & Berardelli, A. (2000). Effects of Botulinum toxin type A on intracortical inhibition in patients with dystonia. Annals of Neurology, 48, 20-26.
17. Gundersen, C. B. (1980). The effects of botulinum toxin on the synthesis, storage and release of acetylcholine. Progress in Neurobiology, 14, 99-119.
18. Habermann, E. (1974). 125-I labeled neurotoxin from Clostridium Botulinum A: A preparation, binding to synaptosomes and ascent to spinal cord. Naunyn-Schmiedeberg's Archives of Pharmacology, 281, 47-56.
19. Hagenah, R., Benecke, R., & Wiegand, H. (1977). Effects of type A Botulinum toxin on the cholinergic transmission at the spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Archives of Pharmacology, 299, 267-272.
20. Ishikawa, H., Mitsui, Y., Yoshitomi, T., Mashimo, K., Aoki, S., Mukuno, K., & Shimizu, K. (2000). Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Japanese Journal of Ophthalmology, 44, 106-109.
21. Kohda, T., Kamata, Y., & Kozaki, S. (2000). Endocytosis of Clostridium botulinum type B neurotoxin into rat brain synaptosomes. The Journal of Veterinary Medical Science, 62, 1133-1138.
22. Kujirai, T., Caramia, M. D., Rothwell, J. C., Day, B. L., Thompson, P. D., Ferbert, A., Wroe, S., Asselman, P., & Marsden, C. D. (1993). Corticocortical inhibition in human motor cortex. Journal of Physiology, 471, 501-519.
23. Mills, K. R., Boniface, S. J., & Schubert, M. (1991). Origin of the secondary increase in firing probability of human motoneurons following transcranial magnetic stimulation. Studies in healthy subjects, type I hereditary motor and sensory neuropathy and multiple sclerosis. Brain, 114, 2451-2463.
24. Rosales, R. L., Arimura, K., Takenaga, S., & Osame, M. (1996). Extrafusal and intrafusal muscle effects in experimental Botulinum toxin-A injection. Muscle & Nerve, 19, 488-496.
25. Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., Cracco, R. Q., Dimitrijevic, M. R., Hallett, M., Katayama, Y., Lucking, C. H., Maertens de Noordhout, A. L., Marsden, C. D., Murray, N. M. F., Rothwell, J. C., Swash, M., & Tomberg, C. (1994). Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFNC committee. Electroencephalograph and Clinical Neurophysiology, 91, 79-92.
26. Scott, A. B. (1981). Botulinum toxin injection of eye muscles to correct strabismus. Transactions of the American Ophthalmological Society, 79, 734-770.
27. Scott, A. B., Kennedy, R. A., & Stubbs, H. A. (1985). Botulinum toxin injection as a treatment for blepharospasm. Archives of Ophthalmology, 103, 347-350.
28. Simpson, D. M., Alexander, D. N., O'Brien, C. F., Tagliati, M., Aswad, A. S., Leon, J. M., Gibson, J., Mordaunt, J. M., & Monaghan, E. P. (1996). Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology, 46, 1306-1310.
29. Sloop, R. R., Escutin, R. O., Matus, J. A., Cole, B. A., & Peterson, G. W. (1995). Dose-response curve of human extensor digitorium brevis muscle function to intramuscular injected botulinum toxin type A. Neurology, 46, 1382-1386.
30. Triggs, W. J., Cros, D., Fang, J., & Chiappa, K. H. (1993). Facilitation of magnetic motor evoked potentials during the cortical stimulation silent period. Neurology, 43, 2615-2620.
31. Wiegand, H., Erdmann, G., & Wellhoner, H. H. (1976). 123I-labeled botulinum A neurotoxin: Pharmacokinetics in cats after intramuscular injection. Naunyn-Schmiedeberg's Archives of Pharmacology, 292, 161-165.
32. Ziemann, U., Rothwell, J. C., & Ridding, M. C. (1996). Interaction between intracortical and facilitation in human motor cortex. Journal of Physiology, 496, 873-881.